Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Lack of deals. Plural. Maybe you don’t follow the biotech space closely, but there has been very few biotech takeover‘s over the last 12 months. And that’s what everyone’s waiting for.
No big Pharma is interested until they see how the uptake is on the drug with all the uncertainties with the high cost and coverage. Boards are much more cautious now. How do I know? Lack of deals. It is that simple..
I fear the 30 minutes ahead of the close today.. No follow through..
Slow but steady would instill confidence back in the name..
Sold some $20 Oct calls as well for a nice premium. If I get $20, that is all I need from this..
Sold quite a few for a nice profit. I don’t like the set up going into earnings..
Up $1.81 on HUGE volume. Options have exploded. See if Pete N runs with this on the halftime report..
Lighten the load……
I eliminated my statins because of Vascepa as my Triglycerides were reduced so much. That is not captured anywhere in the data. Unfortunate.
On fire!!!!! Is it real?
They better go OTC real soon:
https://stocktwits.com/James_Bond/message/360676679
I dare say the market doesn’t like it 6 months out……
I expect the Covid excuse is running out of steam….
$3’s just wow..
Oh brother….
Jess, we could use one of your wildly bullish pep posts right about now…
“Yep, buying auph and BTC for insurance”
LOL…
It’s not Management to blame, they have some extremely talented individuals on the team (Max in sales, and the CSO) and others. It is the price of the drug.
Down again in pre market. Too expensive for the benefit of SOC.
Zzaatt, in your attempt to spread vile here, you incorrectly used words out of context..
$14.40 to $11.50 in 30 days. Scrips are a disaster. $2 million I reckon..
$12.75 to $11.58 in 3 days. Guys, any ideas why the carnage?
Jess, that article on hedge funds interest in AUPH must be yesterday’s news, and they must have reversed course and are now selling aggressively with the price action over the last week. It better bounce at $10.
Dam, this is brutal. Breaking down bad. Fortunately, I sold calls when they were REALLY elevated. The steam is out.
That would be optimistic..
I’m baaaaaack!
‘Thar she blows!!
Leaker…
Greggors, you mean $14 where it broke down?
They are all waiting to see what the sales are for Q2. Nothing else matters. Big bio won’t make a move until they see traction. Getting on a Formulary is good, but actual uptake is what separates the winners from the losers.
I hear the Glickster is back to make sure they hit $3 million..
Cer-v, weak salesforce. Both words
If they make $2 million in sales in Q2, it should be considered a home run. In another three months, it would be considered a touchdown..
Something is wrong…
The gadfly says all is good..
“No BR, it’s not a crap shoot. Lupus world endorses it. No competition in the vicinity, sales will surely come.as there is no equal drug around. It will be years before another drug can challenge it. “
The market doesn’t appear to agree right now. But, give it time, and all that matters is what Peter Greenleaf can do..